Guidance on contraception for women aged over 40 years: response from the CEU.
No Summary Available
Consultant in Sexual and Reproductive Health, NHS Grampian, Square 13 Centre for Sexual and Reproductive Health, Aberdeen Maternity Hospital, Aberdeen, UK; firstname.lastname@example.org.
This article was published in the following journal.
Name: The journal of family planning and reproductive health care / Faculty of Family Planning & Reproductive Health Care, Royal Colle
- PubMed Source: http://www.ncbi.nlm.nih.gov/pubmed/21454284
- DOI: http://dx.doi.org/10.1136/jfprhc.2011.0085
Objective A comprehensive life course perspective of women's experiences in obtaining and using contraception in Australia is lacking. This paper explores free-text comments about contraception provid...
Emergency contraception use is safe for women of all ages, and there are no medical contraindications to its use. The copper intrauterine device is the most effective form, and ulipristal acetate is t...
In light of the recent debate on the use of financial incentives to promote long-acting contraception and sterilisation among women who use illicit drugs we discuss attitudes to contraception, pregnan...
Objective: To examine the uptake of long-acting reversible contraceptive (LARC) methods after abortion among women seeking abortions through a major Australian abortion provider. Design and setting: C...
The annual risk of venous thrombosis has been estimated at 5 to 10 cases per 100 000 women aged 15 to 44 years who are not using hormonal contraception.The risk increases with age for all women. Combi...
In this study, 66 HIV-infected women who desire contraception will be randomly assigned to use either an IUD or Depo Provera, and will be followed for six months. The study is intended to...
This project seeks to demonstrate that computer kiosks in a clinic waiting room can improve access to hormonal contraception and screening for sexually transmitted infections. The study wi...
Depot medroxyprogesterone acetate (DepoProvera) is an acceptable form of contraception for many women. However, difficulty in access may cause many women to discontinue use, often without ...
The purpose of this study is to show that vaccination with a single dose of GSK Biologicals' pandemic H1N1 vaccine results in an immune response that meets or exceeds European Medicines Ag...
A study to determine the efficacy of MK0476 in the Treatment of Asthmatic Patients Aged 2 to 5 Years.
Medical and Biotech [MESH] Definitions
Purplish or brownish red discoloration of the skin associated with increase in circulating polyclonal globulins, usually GAMMA-GLOBULINS. This syndrome often occurs on the legs of women aged 20 to 40 years.
A person 65 through 79 years of age. For a person older than 79 years, AGED, 80 AND OVER is available.
The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age.
A person 80 years of age and older.
Methods of contraception in which physical, chemical, or biological means are used to prevent the SPERM from reaching the fertilizable OVUM.